DE60239690D1 - Sezernierte und zelloberflächengene, die in gutartigen und bösartigen kolorektaltumoren exprimiert werden - Google Patents

Sezernierte und zelloberflächengene, die in gutartigen und bösartigen kolorektaltumoren exprimiert werden

Info

Publication number
DE60239690D1
DE60239690D1 DE60239690T DE60239690T DE60239690D1 DE 60239690 D1 DE60239690 D1 DE 60239690D1 DE 60239690 T DE60239690 T DE 60239690T DE 60239690 T DE60239690 T DE 60239690T DE 60239690 D1 DE60239690 D1 DE 60239690D1
Authority
DE
Germany
Prior art keywords
rdp
mastile
colorektumumors
separated
good
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60239690T
Other languages
German (de)
English (en)
Inventor
Phillip Buckhaults
Kenneth W Kinzler
Bert Vogelstein
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Johns Hopkins University
Original Assignee
Johns Hopkins University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Johns Hopkins University filed Critical Johns Hopkins University
Application granted granted Critical
Publication of DE60239690D1 publication Critical patent/DE60239690D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/495—Transforming growth factor [TGF]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Walking Sticks, Umbrellas, And Fans (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DE60239690T 2001-09-07 2002-09-09 Sezernierte und zelloberflächengene, die in gutartigen und bösartigen kolorektaltumoren exprimiert werden Expired - Lifetime DE60239690D1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US31749401P 2001-09-07 2001-09-07
US38380502P 2002-05-30 2002-05-30
PCT/US2002/028518 WO2003022863A1 (en) 2001-09-07 2002-09-09 Secreted and cell surface genes expressed in benign and malignant colorectal tumors

Publications (1)

Publication Number Publication Date
DE60239690D1 true DE60239690D1 (de) 2011-05-19

Family

ID=26980985

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60239690T Expired - Lifetime DE60239690D1 (de) 2001-09-07 2002-09-09 Sezernierte und zelloberflächengene, die in gutartigen und bösartigen kolorektaltumoren exprimiert werden

Country Status (6)

Country Link
US (1) US8029764B2 (https=)
EP (1) EP1430071B1 (https=)
JP (1) JP2005518781A (https=)
AT (1) ATE504594T1 (https=)
DE (1) DE60239690D1 (https=)
WO (1) WO2003022863A1 (https=)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6927212B2 (en) * 2002-07-27 2005-08-09 The Johns Hopkins University Design and synthesis of renal dipeptidase inhibitors
WO2006066916A1 (en) * 2004-12-23 2006-06-29 Roche Diagnostics Gmbh Use of microsomal dipeptidase as a marker for colorectal cancer
US8217222B2 (en) 2005-09-30 2012-07-10 Anticancer, Inc. Methods for identifying markers for early-stage human cancer, cancer progression and recurrence
CN101971033A (zh) * 2007-06-04 2011-02-09 戴诺普雷克斯公司 用于结直肠癌的生物标志物组合
AU2010310468A1 (en) 2009-10-23 2012-05-24 Mannkind Corporation Cancer immunotherapy and method of treatment
WO2015138879A1 (en) * 2014-03-13 2015-09-17 Massachusetts Institute Of Technology Compositions containing pufa, uridine and choline and methods of use thereof
US20160209415A1 (en) * 2015-01-20 2016-07-21 Poochon Scientific LLC Method to predict or diagnose a colorectal cancer
WO2016164815A1 (en) 2015-04-10 2016-10-13 Applied Proteomics, Inc. Protein biomarker panels for detecting colorectal cancer and advanced adenoma
CN105603093A (zh) * 2016-02-05 2016-05-25 广州复能基因有限公司 以MIC-1 cDNA为模板制备RNA探针的方法
CN109402119A (zh) * 2018-12-11 2019-03-01 宁夏医科大学总医院 一种环状RNA hsa_circTGFBI_001及其特异性扩增引物和应用
CN109402125A (zh) * 2018-12-11 2019-03-01 宁夏医科大学总医院 一种环状RNA hsa_circTGFBI_007及其特异性扩增引物和应用
CN114428172A (zh) * 2022-01-20 2022-05-03 中山大学附属第六医院 用于预测结直肠癌患者术后远处转移风险的标志物及其应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6333152B1 (en) 1997-05-21 2001-12-25 The Johnshopkins University Gene expression profiles in normal and cancer cells

Also Published As

Publication number Publication date
EP1430071A4 (en) 2005-11-02
WO2003022863A1 (en) 2003-03-20
US20040265824A1 (en) 2004-12-30
US8029764B2 (en) 2011-10-04
ATE504594T1 (de) 2011-04-15
JP2005518781A (ja) 2005-06-30
EP1430071B1 (en) 2011-04-06
EP1430071A1 (en) 2004-06-23

Similar Documents

Publication Publication Date Title
WO2004060302A3 (en) Methods and compositions for the diagnosis, prognosis, and treatment of cancer
DE60239690D1 (de) Sezernierte und zelloberflächengene, die in gutartigen und bösartigen kolorektaltumoren exprimiert werden
WO2002009573A3 (en) Prognostic classification of endometrial cancer
WO1998053319A3 (en) Gene expression profiles in normal and cancer cells
WO2004027432A3 (en) Prognostic methods for patients with prostatic disease
AU2001249503A1 (en) High specificity marker detection
WO2000052204A3 (en) Gene expression in bladder tumors
EP2062918A3 (en) Pharmaceutical compositions and methods useful for modulating angiogenesis, inhibiting metastasis and tumor fibrosis, and assessing the malignancy of colon cancer tumors
DE60132498D1 (en) Isoprenoidproduktion
WO2004111273A3 (en) Gene expression markers for response to egfr inhibitor drugs
WO2003086174A3 (en) A new method for the diagnosis and prognosis of malignant diseases
WO2002031507A3 (en) Non-invasive enzyme screen for tissue remodelling-associated conditions
WO2006089233A3 (en) Methods and systems for diagnosis, prognosis and selection of treatment of leukemia
WO2001094629A3 (en) Cancer gene determination and therapeutic screening using signature gene sets
EP2431743A3 (en) Cancer specific glycans and use thereof
WO2004097052A3 (en) Methods for prognosis and treatment of solid tumors
AU2002303444A1 (en) Detection of microsatellite instability and its use in diagnosis of tumors
AU2003227532A1 (en) Mononucleotide repeats microsatellite markers for detecting microsatellite instability.
Saran et al. Genetics of bladder cancer
AU2003228984A1 (en) Methods for cancer prognosis and diagnosis relating to tumor vascular endothelial cells
WO2001030967A3 (en) Fluorescent cobalamins and uses thereof
EP1285970A3 (en) Metastasis-associated genes
WO2004084804A3 (en) Detection and monitoring of lung cancer
WO2004031775A3 (en) Method for treating or preventing metastasis of colorectal cancers
WO2003002765A3 (en) Methods for the diagnosis of cancer based on the obcam and ntm genes